115 related articles for article (PubMed ID: 1652240)
1. Quantitative analysis of the Epstein-Barr virus-inducing properties of short-chain fatty acids present in the culture fluids of oral bacteria.
Asai S; Nakamura Y; Yamamura M; Ikezawa H; Namikawa I
Arch Virol; 1991; 119(3-4):291-6. PubMed ID: 1652240
[TBL] [Abstract][Full Text] [Related]
2. Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells.
Kawanishi M; Ito Y
Cancer Lett; 1980 Dec; 11(2):129-32. PubMed ID: 6257378
[TBL] [Abstract][Full Text] [Related]
3. Induction of Epstein-Barr virus antigens in human lymphoblastoid P3HR-1 cells with culture fluid of Fusobacterium nucleatum.
Ito Y; Kishishita M; Yanase S
Cancer Res; 1980 Nov; 40(11):4329-30. PubMed ID: 6258779
[TBL] [Abstract][Full Text] [Related]
4. Chemically purified serum factor can induce both Epstein-Barr virus antigen synthesis and cell differentiation.
Anisimová E; Roubalová K; Bauer G; Roubal J
Arch Virol; 1987; 94(3-4):309-14. PubMed ID: 3034214
[TBL] [Abstract][Full Text] [Related]
5. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
[TBL] [Abstract][Full Text] [Related]
6. Activation of Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells with propionic acid and with culture fluids of propionic acid-producing anaerobes.
Kishishita M; Yanase S; Ito Y
Cancer Lett; 1982; 16(2):117-20. PubMed ID: 6290028
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus activation by human semen principle: synergistic effect of culture fluids of bacteria isolated from patients with carcinoma of uterine cervix.
Zeng Y; Gi ZW; Ito Y
Cancer Lett; 1985 Sep; 28(3):311-5. PubMed ID: 2996756
[TBL] [Abstract][Full Text] [Related]
8. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of Epstein-Barr virus early antigens by antitubulin agents in a latently infected human lymphoblastoid cell line.
Fujita J; Yoshida O; Tokuda H; Sugawara K; Ito Y
Experientia; 1985 Mar; 41(3):372-3. PubMed ID: 2982647
[TBL] [Abstract][Full Text] [Related]
10. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate.
Roubal J; Luka J; Klein G
Cancer Lett; 1980 Jan; 8(3):209-12. PubMed ID: 6261939
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of chemical Epstein-Barr virus induction by dimethyl sulfoxide and related polar compounds.
Yanase S; Sugawara K
Intervirology; 1989; 30(3):163-8. PubMed ID: 2546900
[TBL] [Abstract][Full Text] [Related]
12. Effect of n-butyrate on superinfection of Raji lymphoblastoid cell line by Epstein-Barr virus.
Roubal J; Roubalová K
Acta Virol; 1985 Mar; 29(2):162-5. PubMed ID: 2860802
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.
Brousset P; Drouet E; Schlaifer D; Icart J; Payen C; Meggetto F; Marchou B; Massip P; Delsol G
AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus activating principle in husbands' semen of cervical cancer patients.
Ida K; Tokuda H; Kanaoka T; Kanzaki H; Noda Y; Yoshida O; Ito Y; Mori T
Am J Reprod Immunol; 1991 Sep; 26(2):89-92. PubMed ID: 1662955
[TBL] [Abstract][Full Text] [Related]
15. Influence of chain length of pyrene fatty acids on their uptake and metabolism by Epstein-Barr-virus-transformed lymphoid cell lines from a patient with multisystemic lipid storage myopathy and from control subjects.
Radom J; Salvayre R; Levade T; Douste-Blazy L
Biochem J; 1990 Jul; 269(1):107-13. PubMed ID: 2165389
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase activity associated with a cell cycle regulated, membrane-bound Epstein-Barr virus induced early antigen.
Kocache MM; Pearson GR
Intervirology; 1990; 31(1):1-13. PubMed ID: 2159954
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumour promotion by various palm-oil tocotrienols.
Goh SH; Hew NF; Norhanom AW; Yadav M
Int J Cancer; 1994 May; 57(4):529-31. PubMed ID: 8181855
[TBL] [Abstract][Full Text] [Related]
18. Identification of the gene product encoded by the PstI repeats (IR4) of the Epstein-Barr virus genome.
Nuebling CM; Mueller-Lantzsch N
Virology; 1991 Nov; 185(1):519-23. PubMed ID: 1656605
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376
[TBL] [Abstract][Full Text] [Related]
20. Porphyromonas endodontalis reactivates latent Epstein-Barr virus.
Makino K; Takeichi O; Imai K; Inoue H; Hatori K; Himi K; Saito I; Ochiai K; Ogiso B
Int Endod J; 2018 Dec; 51(12):1410-1419. PubMed ID: 29858508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
